Work

Midday immune checkpoint inhibitor (ICI) infusion influence on survival in patients with metastatic cancer: A real-world chrono-immunotherapy study.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.11162

Authors: Beliz Bahar Karaoğlan, Mert Karaoğlan, Satı Coskun Yazgan, Duygu Bayır Garbioglu, Metin Demir, Emre Aktop, Elif Berna Koksoy, Pınar Kubilay Tolunay, Hatime Arzu Yasar, Hakan Akbulut, Filiz Cay Senler, Gungor Utkan, Yüksel Ürün, Bulent Yildiz, Emre Yekeduz

Institutions: Ankara University, Eskişehir Osmangazi University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162563181

Cites:

Cited by:

Related to: